Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
暂无分享,去创建一个
[1] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[2] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[3] S. Akira,et al. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. , 2002, International immunology.
[4] J. Bach,et al. Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. , 2003, Journal of autoimmunity.
[5] A. Lanzavecchia,et al. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. , 2003, Blood.
[6] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[7] H. S. Warren,et al. Toll-like receptors. , 2005, Critical care medicine.
[8] Richard A Flavell,et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways , 2003, Nature Immunology.
[9] M. Krečmerová,et al. Lipases as Tools in the Synthesis of Prodrugs from Racemic 9-(2,3-Dihydroxypropyl)adenine , 2012, Molecules.
[10] A Kavanaugh,et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.
[11] P. Plotz,et al. The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.
[12] Cevayir Coban,et al. Genomic DNA Released by Dying Cells Induces the Maturation of APCs1 2 , 2001, The Journal of Immunology.
[13] Jianzhu Chen,et al. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Akira,et al. Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.
[15] S. Akira,et al. Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.
[16] M. Walport,et al. The role of complement in the development of systemic lupus erythematosus. , 2004, Annual review of immunology.
[17] M. Radic,et al. Editors and editing of anti-DNA receptors. , 2001, Immunity.
[18] M. Shlomchik,et al. Activation of autoreactive B cells by CpG dsDNA. , 2003, Immunity.
[19] J. Charles Jennette,et al. Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.
[20] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[21] C. Will,et al. Spliceosomal UsnRNP biogenesis, structure and function. , 2001, Current opinion in cell biology.
[22] J. Hardin. Directing Autoimmunity to Nucleoprotein Particles , 2003, The Journal of experimental medicine.
[23] S. Ikehara,et al. Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow. , 2004, Journal of immunology.
[24] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[25] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[26] P. Allavena,et al. Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells , 2000 .
[27] W. Egner. The use of laboratory tests in the diagnosis of SLE , 2000, Journal of clinical pathology.
[28] E. Tan,et al. Profiles of antinuclear antibodies in systemic rheumatic diseases. , 1975, Annals of internal medicine.
[29] D. Pisetsky,et al. V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. , 1993, Journal of immunology.
[30] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[31] M. Shlomchik,et al. A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.
[32] S. Ikehara,et al. Expansion of Bone Marrow IFN-α-Producing Dendritic Cells in New Zealand Black (NZB) Mice: High Level Expression of TLR9 and Secretion of IFN-α in NZB Bone Marrow , 2004, The Journal of Immunology.
[33] R. Flavell,et al. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. , 1996, Journal of immunology.
[34] L. Aarden,et al. IMMUNOLOGY OF DNA. III. CRITHIDIA LUCILIAE, A SIMPLE SUBSTRATE FOR THE DETERMINATION OF ANTI‐dsDNA WITH THE IMMUNOFLUORESCENCE TECHNIQUE * , 1975, Annals of the New York Academy of Sciences.
[35] A. Clarkson,et al. Rheumatoid factor-like immunoglobulin M protects previously uninfected rat pups and dams from Trypanosoma lewisi. , 1981, Science.
[36] A. Rosen,et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.
[37] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[38] M. Shlomchik,et al. From T to B and back again: positive feedback in systemic autoimmune disease , 2001, Nature Reviews Immunology.
[39] D. Choubey,et al. Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice , 2003, The Journal of experimental medicine.
[40] G. Barber,et al. A FADD-dependent innate immune mechanism in mammalian cells , 2004, Nature.
[41] P. Coulie,et al. Rheumatoid factors and secondary immune responses in the mouse I. Frequent occurrence of hybridomas secreting IgM anti‐IgG1 autoantibodies after immunization with protein antigens , 1983, European journal of immunology.
[42] Persephone Borrow,et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.
[43] H. Yoshida,et al. Lethal anemia caused by interferon-β produced in mouse embryos carrying undigested DNA , 2005, Nature Immunology.
[44] D. Pisetsky,et al. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. , 1999, International immunology.
[45] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[46] W Emlen,et al. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. , 1997, Arthritis and rheumatism.
[47] B. Monks,et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.
[48] V. Kelley,et al. Induction of various autoantibodies by mutant gene lpr in several strains of mice. , 1984, Journal of immunology.
[49] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[50] M. Radic,et al. Structural basis for autoantibody recognition of phosphatidylserine-β2 glycoprotein I and apoptotic cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Akira,et al. Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells , 2004, Journal of endotoxin research.
[52] T. Giese,et al. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.
[53] K. Tung,et al. Breaking Tolerance to Double Stranded DNA, Nucleosome, and Other Nuclear Antigens Is Not Required for the Pathogenesis of Lupus Glomerulonephritis , 2004, The Journal of experimental medicine.
[54] M. Monestier,et al. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. , 1992, Rheumatic diseases clinics of North America.
[55] G. Hughes,et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis , 2003, Annals of the rheumatic diseases.
[56] S. Nagata,et al. Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation. , 2002, Genes & development.
[57] J. Bach,et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. , 1994, Arthritis and rheumatism.
[58] A. Todd-Pokropek,et al. Measurement of anti-DNA antibodies: a reappraisal using five different methods. , 1987, Annals of the rheumatic diseases.
[59] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[60] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[61] M. Cygler,et al. Antibodies to DNA , 1988, BioEssays : news and reviews in molecular, cellular and developmental biology.
[62] M. Madaio,et al. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. , 1992, Kidney international.
[63] A. Krieg,et al. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. , 2003, International immunology.
[64] J. Steitz,et al. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. , 1984, The Journal of biological chemistry.
[65] P. Coulie,et al. Rheumatoid factors and secondary immune responses in the mouse II. Incidence, kinetics and induction mechanisms , 1983, European journal of immunology.
[66] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[67] R Hal Scofield,et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.
[68] Jonathan D. Hron,et al. Type I IFN Protects Against Murine Lupus1 , 2004, The Journal of Immunology.
[69] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] M. Shlomchik,et al. The role of B cells in lpr/lpr-induced autoimmunity , 1994, The Journal of experimental medicine.